Skip to content
MedsAcross

Medicine

Premarin 0.625 mg tablet

Estrogens, conjugated · Oral · Wyeth Pharmaceuticals
Available on requestPrescription onlyUS FDA

Premarin 0.625 mg tablet is a prescription medicine containing Estrogens, conjugated for oral use, marketed by Wyeth Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…

Key facts

Active ingredient (INN)
Estrogens, conjugated
Brand
Premarin
Strength
0.625 mg
Dosage form
Tablet
Route
Oral
Packs
1 blister pack, 100 tablets, 1 bottle and 2 more
Marketing authorisation holder
Wyeth Pharmaceuticals
Manufacturers
Wyeth PharmaceuticalsA-S Medication Solutions
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
G03CA57 Estrogens, conjugated
HS code (indicative)
3004.39Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 January 2006
Identifiers
RxCUI 150840, 310197, 197660 +7DailyMed set ID a3b86b85-8923-42ae-aa31-a66a6e090327, 258e1602-a3cf-4ccc-ca80-73dbbfb812ffNDC 50090-0167, 0046-1102Application NDA004782

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 blister pack in 1 carton / 5 tablet, film coated in 1 blister pack0046-1102-52Wyeth Pharmaceuticals10 February 2020
100 tablet, film coated in 1 bottle0046-1102-81Wyeth Pharmaceuticals1 January 2006
1 bottle in 1 carton / 1000 tablet, film coated in 1 bottle0046-1102-91Wyeth Pharmaceuticals1 January 2006
100 tablet, film coated in 1 bottle50090-0167-0A-S Medication Solutions29 October 2018
30 tablet, film coated in 1 bottle50090-0167-5A-S Medication Solutions21 June 2016

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 8 May 1942Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Estrogens, conjugated 0.625 mg tablet.

Compare 1

Other strengths and forms of Estrogens, conjugated

Clinical summary

Estrogens, conjugated is an estrogen indicated for treatment of Moderate to Severe Vasomotor Symptoms due to Menopause, among other approved uses. MedsAcross supplies Estrogens, conjugated for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Estrogens, conjugated

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Premarin 0.625 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.